Literature DB >> 17975304

Protective effect of (+/-) isoborneol against 6-OHDA-induced apoptosis in SH-SY5Y cells.

Lin-Lin Tian1, Zhe Zhou, Qi Zhang, Yu-Ning Sun, Chun-Rong Li, Chang-He Cheng, Z-Y Zhong, Sheng-Qi Wang.   

Abstract

Oxidative stress caused by dopamine (DA) may play an important role in the pathogenesis of Parkinson's disease (PD). (+/-) Isoborneol is a monoterpenoid alcohol present in the essential oils of numerous medicinal plants and is a known antioxidant. In this study, we investigated the neuroprotective effect of isoborneol against 6-hydroxydopamine (6-OHDA)-induced cell death in human neuroblastoma SH-SY5Y cells. Pretreatment of SH-SY5Y cells with isoborneol significantly reduced 6-OHDA-induced generation of reactive oxygen species (ROS) and 6-OHDA-induced increases in intracellular calcium. Furthermore, apoptosis induced by 6-OHDA was reversed by isoborneol treatment. Isoborneol protected against 6-OHDA-induced increases in caspase-3 activity and cytochrome C translocation into the cytosol from mitochondria. Isoborneol prevented 6-OHDA from decreasing the Bax/Bcl-2 ratio. We also observed that isoborneol decreased the activation of c-Jun N-terminal kinase and induced activation of protein kinase C (PKC) which had been suppressed by 6-OHDA. Our results indicate that the protective function of isoborneol is dependent upon its antioxidant potential and strongly suggest that isoborneol may be an effective treatment for neurodegenerative diseases associated with oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17975304     DOI: 10.1159/000110682

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  20 in total

Review 1.  Mitochondrial kinases in Parkinson's disease: converging insights from neurotoxin and genetic models.

Authors:  Ruben K Dagda; Jianhui Zhu; Charleen T Chu
Journal:  Mitochondrion       Date:  2009-06-27       Impact factor: 4.160

2.  PKCδ inhibition enhances tyrosine hydroxylase phosphorylation in mice after methamphetamine treatment.

Authors:  Eun-Joo Shin; Chu Xuan Duong; Xuan-Khanh Thi Nguyen; Guoying Bing; Jae-Hyung Bach; Dae Hun Park; Keiichi Nakayama; Syed F Ali; Anumantha G Kanthasamy; Jean L Cadet; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Neurochem Int       Date:  2011-06-13       Impact factor: 3.921

3.  Inhibition by anandamide of 6-hydroxydopamine-induced cell death in PC12 cells.

Authors:  Katarzyna Mnich; David P Finn; Eilis Dowd; Adrienne M Gorman
Journal:  Int J Cell Biol       Date:  2010-02-16

4.  Protective effect of hydrogen sulphide against 6-OHDA-induced cell injury in SH-SY5Y cells involves PKC/PI3K/Akt pathway.

Authors:  Chi Xin Tiong; Ming Lu; Jin-Song Bian
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

5.  Overexpression of alpha-synuclein down-regulates BDNF expression.

Authors:  Yuhe Yuan; Jiandong Sun; Ming Zhao; Jinfeng Hu; Xiaoliang Wang; Guohua Du; Nai-Hong Chen
Journal:  Cell Mol Neurobiol       Date:  2010-04-20       Impact factor: 5.046

6.  Myricitrin alleviates methylglyoxal-induced mitochondrial dysfunction and AGEs/RAGE/NF-κB pathway activation in SH-SY5Y cells.

Authors:  Yue-Hua Wang; Hai-Tao Yu; Xiao-Ping Pu; Guan-Hua Du
Journal:  J Mol Neurosci       Date:  2014-02-09       Impact factor: 3.444

7.  Agmatine Protects Against 6-OHDA-Induced Apoptosis, and ERK and Akt/GSK Disruption in SH-SY5Y Cells.

Authors:  Esmat Amiri; Rasoul Ghasemi; Maryam Moosavi
Journal:  Cell Mol Neurobiol       Date:  2015-09-07       Impact factor: 5.046

8.  Sensitive assay for measurement of volatile borneol, isoborneol, and the metabolite camphor in rat pharmacokinetic study of Borneolum (Bingpian) and Borneolum syntheticum (synthetic Bingpian).

Authors:  Chen Cheng; Xin-Wei Liu; Fei-Fei Du; Mei-Juan Li; Fang Xu; Feng-Qing Wang; Yang Liu; Chuan Li; Yan Sun
Journal:  Acta Pharmacol Sin       Date:  2013-08-26       Impact factor: 6.150

Review 9.  Natural Compounds as Medical Strategies in the Prevention and Treatment of Psychiatric Disorders Seen in Neurological Diseases.

Authors:  Esra Küpeli Akkol; Irem Tatlı Çankaya; Gökçe Şeker Karatoprak; Elif Carpar; Eduardo Sobarzo-Sánchez; Raffaele Capasso
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

Review 10.  Recent advances on the neuroprotective potential of antioxidants in experimental models of Parkinson's disease.

Authors:  Sushruta Koppula; Hemant Kumar; Sandeep Vasant More; Byung Wook Kim; In Su Kim; Dong-Kug Choi
Journal:  Int J Mol Sci       Date:  2012-08-23       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.